|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu chiun"
Showing items 1-50 of 149 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-02-24T03:41:50Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang, Fan-Chi; Chen, Tom Wei-Wu; Huang, Thomas Tao-Min; Lin, Wei-Chou; Liu, Jia-Sin; Chiang, Wen-Chih; Chen, Yung-Ming; Hsu, Chiun; Yeh, Kun-Huei; TZONG-SHINN CHU |
| 臺大學術典藏 |
2022-02-22T08:10:53Z |
Fully digital problem-based learning for undergraduate medical students during the COVID-19 period: Practical considerations
|
Chao, Chia-Ter; Tsai, Chiao-Lin; Lin, Mong-Wei; CHIH-WEI YANG; Ho, Chao-Chi; Chen, Huey-Ling; Hsu, Chiun; Sheu, Bor-Ching |
| 臺大學術典藏 |
2020-06-11T06:40:55Z |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14).
|
Chen, Ming-Huang;Chou, Wen-Chi;Hsiao, Chin-Fu;Liu, Yi-Chang;Hsu, Chiun;Yanshen, Shan;Hung, Yi-Ping;Hsieh, Chia-Hsun;Chiu, Chao-Hua;Liu, Ta-Chih;Cho, Shih-Feng;Liu, Tsang-Wu;Chao, Yee; Chen, Ming-Huang; Chou, Wen-Chi; Hsiao, Chin-Fu; Liu, Yi-Chang; Hsu, Chiun; Yanshen, Shan; Hung, Yi-Ping; Hsieh, Chia-Hsun; Chiu, Chao-Hua; Liu, Ta-Chih; Cho, Shih-Feng; Liu, Tsang-Wu; Chao, Yee; YI-PING HUNG |
| 臺大學術典藏 |
2020-04-09T09:36:48Z |
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
|
Hsu, Chiun; Lin, Liang-In; Cheng, Yu-Che; Feng, Zi-Rui; Shao, Yu-Yun; Cheng, Ann-Lii; Ou, Da-Liang |
| 臺大學術典藏 |
2020-04-09T09:34:35Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Cheng, Ann Lii;Hsu, Chih Hung;Lin, Zhong Zhe;Hsu, Chiun;Shen, Ying Chun;Lu, Li Chun;Shao, Yu Yun;Liu, Tsung Hao; Liu, Tsung Hao; Shao, Yu Yun; Lu, Li Chun; Shen, Ying Chun; Hsu, Chiun; Lin, Zhong Zhe; Hsu, Chih Hung; Cheng, Ann Lii |
| 臺大學術典藏 |
2019-12-25T07:19:04Z |
Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
|
Xu, Cheng; Chen, Yu-Pei; Du, Xiao-Jing; Liu, Jin-Qi; Huang, Cheng-Long; Chen, Lei; Zhou, Guan-Qun; Li, Wen-Fei; Mao, Yan-Ping; Hsu, Chiun; Liu, Qing; Lin, Ai-Hua; Tang, Ling-Long; Sun, Ying; Ma, Jun; YU-PEI CHEN |
| 臺大學術典藏 |
2019-10-16T08:39:08Z |
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma
|
Lin, Zhong-Zhe;Hsu, Chiun;Yung-Ming Jeng;Hu, Fu-Chang;Pan, Hung-Wei;Yao-Ming Wu;Hsu, Hey-Chi;Ann-Lii Cheng; Lin, Zhong-Zhe; Hsu, Chiun; YUNG-MING JENG; Hu, Fu-Chang; Pan, Hung-Wei; YAO-MING WU; Hsu, Hey-Chi; ANN-LII CHENG |
| 臺大學術典藏 |
2019-09-09T00:55:32Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Li Chun;YU-YUN SHAO;Shen, Ying Chun;Hsu, Chiun;YI-PING HUNG;CHIH-HUNG HSU;Liu, Tsung Hao;ANN-LII CHENG;Guo, Jhe Cyuan;Yen, Chia Jui;Chang, Chun Jung;I-LUN SHIH;Chao, Yee; Chao, Yee; I-LUN SHIH; Chang, Chun Jung; Yen, Chia Jui; Guo, Jhe Cyuan; ANN-LII CHENG; Liu, Tsung Hao; CHIH-HUNG HSU; YI-PING HUNG; Hsu, Chiun; Shen, Ying Chun; YU-YUN SHAO; Lu, Li Chun |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2019-04-24T02:30:32Z |
Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis
|
Hsiue, Emily Han-Chung;Hsu, Chiun;Li-Hui Tseng;T.-P. Lu;Kuan-Ting Kuo; Hsiue, Emily Han-Chung; Hsu, Chiun; LI-HUI TSENG; T.-P. LU; KUAN-TING KUO |
| 臺大學術典藏 |
2018-09-10T15:33:37Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, S.-H. and Kuo, T.-C. and Wu, H. and Guo, J.-C. and Hsu, C. and Hsu, C.-H. and Tien, Y.-W. and Yeh, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; 郭頌鑫;鄭安理;徐志宏;許駿;葉坤輝;郭哲銓;田郁文;郭庭均;楊士弘; Yang, Shih-Hung; TING-CHUN KUO; Yang, Shih-Hung; Yang, Shih-Hung; Kuo, Ting-Chun; Kuo, Ting-Chun; YU-WEN TIEN; Kuo, Ting-Chun; ANN-LII CHENG; Wu, Hsu; Guo, Jhe-Cyuan; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chiun; Hsu, Chih-Hung; Hsu, Chih-Hung; Tien, Yu-Wen; Tien, Yu-Wen; Tien, Yu-Wen; Yeh, Kun-Huei; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2018-09-10T15:20:52Z |
Modulatory Effects of Astragalus Polysaccharides on T-Cell Polarization in Mice with Polymicrobial Sepsis
|
?謅???:rp06391; ?????:rp06606; ?格╰撠糕|??銋?:rp06437; Hsu, Chiun; Hou, Yu-Chen; JIN-MING WU; Lin, Liang-In; Kuen-Yuan Chen; Wu, Jin-Ming; MING-TSAN LIN; Cheng, Yu-Che; Wang, Ming-Yang; Ming-Hsun Wu; Wu, Ming-Hsun; Feng, Zi-Rui; Shao, Yu-Yun; Chen, Kuen-Yuan; Cheng, Ann-Lii; Yeh, Sung-Ling; Lin, Ming-Tsan; Ou, Da-Liang; ????:rp06865; 陳坤源;林明燦;吳明勳;吳經閔;王明暘; Hou, Yu-Chen;Wu, Jin-Ming;Wang, Ming-Yang;Wu, Ming-Hsun;Chen, Kuen-Yuan;Yeh, Sung-Ling;Lin, Ming-Tsan; Hou, Y.-C. and Wu, J.-M. and Wang, M.-Y. and Wu, M.-H. and Chen, K.-Y. and Yeh, S.-L. and Lin, M.-T. |
| 臺大學術典藏 |
2018-09-10T15:18:35Z |
Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
|
Hsu, Chiun;Chen, Bang-Bin;Chen, Chien-Hung;Ho, Ming-Chih;Cheng, Jason Chia-Hsien;Kokudo, Norihiro;Murakami, Takamichi;Yeo, Winnie;Seong, Jinsil;Jia, Ji-Dong;Han, Kwan-Hyub;Cheng, Ann-Lii; 鄭安理;成佳憲;陳邦斌;許駿;陳健弘;何明志; Hsu, Chiun; MING-CHIH HO; Hsu, Chiun; Chen, Bang-Bin; Chen, Bang-Bin; BANG-BIN CHEN; Wu, Chien-Te; Libertus, Melissa E.; ANN-LII CHENG; Chen, Chien-Hung; Chen, Chien-Hung; Meyerhoff, Karen L.; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Jason Chia-Hsien; Woldorff, Marty G.; Kokudo, Norihiro; Kokudo, Norihiro; Murakami, Takamichi; Murakami, Takamichi; Yeo, Winnie; Seong, Jinsil; Seong, Jinsil; Jia, Ji-Dong; Han, Kwan-Hyub; Cheng, Ann-Lii; 吳建德; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T15:02:42Z |
Preparation of induced pluripotent stem cells on dishes grafted on oligopeptide under feeder-free conditions
|
Higuchi, Akon;Lin, Feng-Ling;Cheng, Yu-Kai;Kao, Ta-Chun;Kumar, S. Suresh;Ling, Qing-Dong;Hou, Chun-Han;Chen, Da-Chung;Hsu, Shih-Tien;Wu, Gwo-Jang; Higuchi, A. and Lin, F.-L. and Cheng, Y.-K. and Kao, T.-C. and Kumar, S.S. and Ling, Q.-D. and Hou, C.-H. and Chen, D.-C. and Hsu, S.-T. and Wu, G.-J.; 侯君翰; Chun-Han Hou; Chen, Bang-Bin; Higuchi, Akon; Lin, Feng-Ling; Shih, I-Lun; Wu, Chih-Horng; Cheng, Yu-Kai; Hsu, Chiun; Kao, Ta-Chun; Chen, Chien-Hung; Kumar, S. Suresh; Ling, Qing-Dong; Shih, Tiffany Ting-Fang; Liu, Kao-Lang; Hou, Chun-Han; Chen, Da-Chung; Liang, Po-Chin; Hsu, Shih-Tien; Wu, Gwo-Jang; ?d???; ?I?x??; ?????y; ?\?@; ?I???; ??????; ?B????; ???? |
| 臺大學術典藏 |
2018-09-10T15:01:52Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Chen, Bang-Bin;Shih, I-Lun;Wu, Chih-Horng;Hsu, Chiun;Chen, Chien-Hung;Shih, Tiffany Ting-Fang;Liu, Kao-Lang;Liang, Po-Chin; Chen, B.-B. and Shih, I.-L. and Wu, C.-H. and Hsu, C. and Chen, C.-H. and Shih, T.T.-F. and Liu, K.-L. and Liang, P.-C.; 吳志宏;施庭芳;陳邦斌;許駿;施怡倫;陳健弘;劉高郎;梁博欽; Chen, Bang-Bin; TIFFANY TING-FANG SHIH; Shih, I-Lun; CHIH-HORNG WU; Wu, Chih-Horng; PO-CHIN LIANG; KAO-LANG LIU; Hsu, Chiun; I-LUN SHIH; Chen, Chien-Hung; BANG-BIN CHEN; Shih, Tiffany Ting-Fang; Liu, Kao-Lang; Liang, Po-Chin |
| 臺大學術典藏 |
2018-09-10T14:58:12Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, D.-L. and Chang, C.-J. and Jeng, Y.-M. and Lin, Y.-J. and Lin, Z.-Z. and Gandhi, A.K. and Liao, S.-C. and Huang, Z.-M. and Hsu, C. and Cheng, A.-L.; Ou, Da-Liang;Chang, Chun-Jung;Jeng, Yung-Ming;Lin, Yi-Jang;Lin, Zhong-Zhe;Gandhi, Anita K.;Liao, Sheng-Chieh;Huang, Zi-Ming;Hsu, Chiun;Cheng, Ann-Lii; 鄭永銘;張純榮;林宗哲;鄭安理;許駿;歐大諒; YUNG-MING JENG; Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; �G�w�z |
| 臺大學術典藏 |
2018-09-10T14:50:09Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, Y.-C. and Li, C.-P. and Yen, C.-J. and Hsu, C. and Lin, Y.-L. and Lin, Z.-Z. and Chen, L.-T. and Su, W.-C. and Chao, Y. and Yeh, K.-H. and Cheng, A.-L.; Shen, Ying-Chun;Li, Chung-Pin;Yen, Chia-Jui;Hsu, Chiun;Lin, Yu-Lin;Lin, Zhong-Zhe;Chen, Li-Tzong;Su, Wu-Chou;Chao, Yee;Yeh, Kun-Huei;Cheng, Ann-Lii; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; KUN-HUEI YEH; Shen, Ying-Chun; Shen, Ying-Chun; Li, Chung-Pin; YU-LIN LIN; Li, Chung-Pin; Yen, Chia-Jui; ANN-LII CHENG; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Yu-Lin; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T14:49:20Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Liang, Ja-Der; Liang, Ja-Der; Tien, Yu-Wen; Tien, Yu-Wen; Hsu, Chiun; Hsu, Chiun; Wong, Jau-Min; Wong, Jau-Min; Chang, Yu-Ting; Chang, Yu-Ting; Chen, Chien-Hung; Chang, M.-C. and Chen, C.-H. and Liang, J.-D. and Tien, Y.-W. and Hsu, C. and Wong, J.-M. and Chang, Y.-T.; Chang, Ming-Chu;Chen, Chien-Hung;Liang, Ja-Der;Tien, Yu-Wen;Hsu, Chiun;Wong, Jau-Min;Chang, Yu-Ting; 翁昭旼;許駿;章明珠;田郁文;陳健弘;張毓廷;梁嘉德; 章明珠; YU-TING CHANG; Chang, Ming-Chu; Chen, Chien-Hung; YU-WEN TIEN |
| 臺大學術典藏 |
2018-09-10T14:49:19Z |
Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan
|
Chang, Y.-T. and Chang, M.-C. and Huang, K.-W. and Tung, C.-C. and Hsu, C. and Wong, J.-M.; Chang, Yu-Ting;Chang, Ming-Chu;Huang, Kai-Wen;Tung, Chien-Chih;Hsu, Chiun;Wong, Jau-Min; Chang, Yu-Ting;Chang, Ming-Chu;Huang, Kai-Wen;Tung, Chien-Chih;Hsu, Chiun;Wong, Jau-Min; 董建志;黃凱文;許駿;章明珠;張毓廷; Chang, Yu-Ting; YU-TING CHANG; Chang, Yu-Ting; KAI-WEN HUANG; Chang, Ming-Chu; Huang, Kai-Wen; Huang, Kai-Wen; Tung, Chien-Chih; Tung, Chien-Chih; Hsu, Chiun; Wong, Jau-Min; Chang, Hao-Hueng |
| 臺大學術典藏 |
2018-09-10T09:16:02Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu, Chiun;Shen, Ying-Chun;Cheng, Chia-Chi;Cheng, Ann-Lii;Hu, Fu-Chang;Yeh, Kun-Huei; Hsu, C. and Shen, Y.-C. and Cheng, C.-C. and Cheng, A.-L. and Hu, F.-C. and Yeh, K.-H.; 鄭安理 ;許駿 ;葉坤輝; Hsu, Chiun; KUN-HUEI YEH; Hsu, Chiun; Shen, Ying-Chun; ANN-LII CHENG; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Hu, Fu-Chang; Yeh, Kun-Huei; Yeh, Kun-Huei |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T07:19:44Z |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen, Y.-C. and Hu, F.-C. and Jeng, Y.-M. and Chang, Y.-T. and Lin, Z.-Z. and Chang, M.-C. and Hsu, C. and Cheng, A.-L.; 沈盈君;胡賦強;鄭永銘;張毓廷;林宗哲;章明珠;許駿;鄭安理; SHEN, YING-CHUN;HU, FU-CHANG;JENG, YUNG-MING;CHANG, YU-TING;LIN, ZONG-ZHE;CHANG, MING-CHU;HSU, CHIUN;CHENG, ANN-LII; YUNG-MING JENG; YU-TING CHANG; ANN-LII CHENG; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII |
| 國立成功大學 |
2016-05 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong |
| 國立成功大學 |
2016-02-01 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC).
|
Chiang, Nai-Jung; Tsai, Kelvin K.; Chen, Jen-Shi; Yang, Shih-Hung; Hsu, Chiun; Shan, Yan-Shen; Chen, Li-Tzong |
| 國立臺灣大學 |
2016 |
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
|
Hsu, Chiun; Lin, Liang-In; Cheng, Yu-Che; Feng, Zi-Rui; Shao, Yu-Yun; Cheng, Ann-Lii; Ou, Da-Liang; 邵幼雲; 林亮音; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, Shih-Hung; Kuo, Ting-Chun; Wu, Hsu; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chih-Hung; Tien, Yu-Wen; Yeh, Kun-Huei; Cheng, Ann-Lii; Kuo, Sung-Hsin; 郭頌鑫; 鄭安理; 徐志宏; 許駿; 葉坤輝; 郭哲銓; 田郁文; 郭庭均; 楊士弘 |
| 國立臺灣大學 |
2016 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong; 許駿 |
| 國立臺灣大學 |
2016 |
Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
|
Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Liang, Po-Chin; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shih, Tiffany Ting-Fang; 許昭禹; 鄭安理; 陳邦斌; 徐志宏; 許駿; 梁博欽; 游治維 |
| 國立臺灣大學 |
2016 |
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
|
Lu, Li-Chun; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立成功大學 |
2015-04 |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Liang, Po-Chin; Ch'ang, Hui-Ju; Hsu, Chiun; Chen, Li-Tzong; Shih, Tiffany T. F.; Liu, Tsang Wu |
| 國立臺灣大學 |
2015 |
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou, Da-Liang; Shyue, Song-Kun; Lin, Liang-In; Feng, Zi-Rui; Liou, Jun-Yang; Fan, Hsiang-Hsuan; Lee, Bin-Shyun; Hsu, Chiun; Cheng, Ann-Lii; 林亮音; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2015 |
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia
|
Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu-Yun; Hsu, Chiun; Cheng, Wen-Fan; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 郭漢岳; 郭弘揚; 鄭文芳; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 許駿 |
| 國立臺灣大學 |
2015 |
Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)
|
Hsu, Chiun; Chen, Bang-Bin; Chen, Chien-Hung; Ho, Ming-Chih; Cheng, Jason Chia-Hsien; Kokudo, Norihiro; Murakami, Takamichi; Yeo, Winnie; Seong, Jinsil; Jia, Ji-Dong; Han, Kwan-Hyub; Cheng, Ann-Lii; 鄭安理; 成佳憲; 陳邦斌; 許駿; 陳健弘; 何明志 |
| 國立成功大學 |
2014-01-20 |
Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hiso-Hui; Chao, Yee; Shan, Yang-Shen; Huang, Shiu-Feng; Chiu, Chang-Fang; Lee, Kuan-Der; Chen, Li-Tzong |
| 國立成功大學 |
2014 |
Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
|
Shen, Ying-Chun; Li, Chung-Pin; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 國立臺灣大學 |
2014 |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Vertical blockade of the IGFR-PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
|
Ou, Da-Liang; Lee, Bin-Shyun; Lin, Liang-In; Liou, Jun-Yang; Liao, Sheng-Chieh; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
|
Shen, Ying-Chun; Li, Chung-Pin; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Cheng, Ann-Lii; 林宗哲; 林育麟; 鄭安理; 許駿; 葉坤輝 |
| 國立臺灣大學 |
2014 |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
Kao, Hsiang-Fong; Chen, I-Chun; Hsu, Chiun; Chang, Sin-Yuan; Chien, Shu-Fen; Chen, Yee-Chun; Hu, Fu-Chang; Yang, James Chih-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei; 楊志新; 高祥豐; 陳怡君; 鄭安理; 許駿; 葉坤輝; 陳宜君 |
| 國立臺灣大學 |
2014 |
The impact of diabetes mellitus on early cervical cancer in Asia: A population-based cohort study
|
Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu Yun; Hsu, Chiun; Chang, Wen-Fang; Chang, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 鄭安理; 許駿; 賴秋伶 |
| 國立臺灣大學 |
2014 |
Comparison of Characteristics and Transarterial Chemoembolization Outcomes in Patients with Unresectable Hepatocellular Carcinoma and Different Viral Etiologies
|
Chen, Bang-Bin; Shih, I-Lun; Wu, Chih-Horng; Hsu, Chiun; Chen, Chien-Hung; Shih, Tiffany Ting-Fang; Liu, Kao-Lang; Liang, Po-Chin; 吳志宏; 施庭芳; 陳邦斌; 許駿; 施怡倫; 陳健弘; 劉高郎; 梁博欽 |
| 國立臺灣大學 |
2014 |
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
|
Hsu, Chiun; Tsou, Hsiao-Hui; Lin, Shyh-Jer; Wang, Ming-Chung; Yao, Ming; Hwang, Wen-Li; Kao, Woei-Yau; Chiu, Chang-Fang; Lin, Sheng-Fung; Lin, Johnson; Chang, Cheng-Shyong; Tien, Hwei-Fang; Liu, Tsang-Wu; Chen, Pei-Jer; Cheng, Ann-Lii; 姚明; 鄭安理; 許駿; 田蕙芬; 陳培哲 |
| 國立臺灣大學 |
2014 |
H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
|
Wu, Pei-Chun; Lu, Jeng-Wei; Yang, Jer-Yen; Lin, I-Hsuan; Ou, Da-Liang; Lin, Yu-Hsiang; Chou, Kuan-Hsien; Huang, Wen-Feng; Wang, Wan-Ping; Huang, Yih-Leh; Hsu, Chiun; Lin, Liang-In; Lin, Yueh-Min; Shen, C. -K. James; Tzeng, Tsai-Yu; 林亮音; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan
|
Chang, Yu-Ting; Chang, Ming-Chu; Huang, Kai-Wen; Tung, Chien-Chih; Hsu, Chiun; Wong, Jau-Min; 董建志; 黃凱文; 許駿; 章明珠; 張毓廷 |
| 國立臺灣大學 |
2014 |
Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC)
|
Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 林宗哲; 鄭安理; 許駿; 陳昆鋒; 歐大諒 |
| 國立臺灣大學 |
2014 |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang, Ming-Chu; Chen, Chien-Hung; Liang, Ja-Der; Tien, Yu-Wen; Hsu, Chiun; Wong, Jau-Min; Chang, Yu-Ting; 翁昭旼; 許駿; 章明珠; 田郁文; 陳健弘; 張毓廷; 梁嘉德 |
| 國立臺灣大學 |
2014 |
Strategy for Preventing Hepatitis B Reactivation in Patients With Resolved Hepatitis B Virus Infection After Rituximab-Containing Chemotherapy Reply
|
Hsu, Chiun; Chen, Pei-Jer; Cheng, Ann-Lii; 鄭安理; 許駿 |
| 國立成功大學 |
2013-05-20 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, Li-Tzong; Chen, Jen-Shi; Chao, Yee; Tsai, Chang-Sung; Shan, Yan-Shen; Hsu, Chiun; Huang, Shiu-Feng; Tsou, Hsiao-Hui; Lee, Kuan-Der; Chiu, Chang-Fang; Rau, Kun-Ming; Ho, Ching-Liang; Yu, Ming-Sun |
| 國立成功大學 |
2013 |
Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
|
Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii |
| 國立臺灣大學 |
2013 |
14-3-3 epsilon Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
|
Liu, Tzu-An; Jan, Yee-Jee; Ko, Bor-Sheng; Liang, Shu-Man; Chen, Shyh-Chang; Wang, John; Hsu, Chiun; Wu, Yao-Ming; Liou, Jun-Yang; 柯博升; 許駿; 吳耀銘 |
Showing items 1-50 of 149 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
